Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$0.11
-$0.01(-9.02%)
At close: 4:00 PM EDT
$0.11
-$0.01(-9.02%)
Day’s Range― - ―
52-Week Range$1.55 - $77.10
Previous Close$2.49
Volume2.03M
Average Volume (3M)5.50M
Market Cap
$1.97M
Enterprise Value$10.02
Total Cash (Recent Filing)$1.74M
Total Debt (Recent Filing)$13.85M
Price to Earnings (P/E)―
Beta1.64
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-34.37
Shares Outstanding618,899
10 Day Avg. Volume16,237,908
30 Day Avg. Volume5,498,676
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-9.63
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Multi-channel Regulated-market ModelThe combination of wholesale and direct-to-consumer channels gives IMCC multiple routes to monetize its cannabis products. Exposure to both medical and adult-use demand can broaden revenue opportunities and provide flexibility as market conditions and regulations evolve.
Integrated Operating PlatformControl across importing, distribution, retail pharmacies, online sales, and pharmacy supply can improve coordination from product sourcing through delivery. This integrated platform, supported by proprietary patient data, may help the company manage quality and tailor offerings.
Established Israel And Germany FootprintAn established operating presence in two regulated medical cannabis markets provides existing infrastructure, market knowledge, and customer relationships. That footprint offers a foundation for rebuilding sales and improving execution without starting market entry from scratch.
Bears Say
Declining Revenue And Persistent LossesThe sharp revenue contraction shows weakening demand or execution across the current footprint, while widening losses indicate that the cost base is not scaling with sales. Without a sustained top-line recovery, profitability and funding capacity will remain under pressure.
Negative Equity And Elevated LeverageA shareholders’ deficit combined with liabilities materially exceeding cash leaves IMCC with limited financial flexibility. The weakened capitalization increases refinancing pressure and reduces the company’s ability to fund operations or growth from its existing balance sheet.
Recent Cash Burn And Inconsistent GenerationRecent negative operating and free cash flow means the business is consuming cash rather than self-funding operations. Although prior-year generation was positive and free cash flow improved versus the preceding period, the reversal demonstrates that cash conversion is not yet dependable.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $1.55 and its highest was $77.10 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $1.97M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Nov 16, 2026 which is in 51 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Aug 13, 2026. The company reported -$10.198 earnings per share for the quarter.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 618,899 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$10.198 in its last earnings report. Following the earnings report the stock price went down -6.053%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
4.09% Insiders
―
Mutual Funds
― Other Institutional Investors
95.91% Public Companies and
Individual Investors